» Articles » PMID: 18986313

Marginal Excision of Low-grade Spindle Cell Sarcoma of Canine Extremities: 35 Dogs (1996-2006)

Overview
Journal Vet Surg
Date 2008 Nov 7
PMID 18986313
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate recurrence rate and disease-free interval (DFI) of dogs with low-grade soft tissue spindle cell sarcoma of the extremities treated by marginal excision.

Study Design: Retrospective study.

Animals: Dogs (n=35) with soft tissue low-grade spindle cell sarcoma.

Methods: Medical records were reviewed and dogs that had marginal surgical resection of low-grade soft tissue spindle cell sarcoma at or distal to elbow and stifle were included.

Results: Histopathologic margins were dirty (12 dogs), clean but close (12), and clean (11). Follow-up after surgery occurred from 210 to 2202 days (minimum, 180 days). Local recurrence and metastatic rates were 10.8% and 0%, respectively. Median DFI and survival time were not reached, because <50% of dogs died of disease-related events. Mean DFI and mean survival time were 697.8 days (95% CI: 559.7-836 days) and 703.5 days (95% CI: 566.6-840.5 days), respectively. There were no significant differences among survival functions stratified by histologic margins.

Conclusion: Marginal surgical excision without adjuvant treatment of low-grade soft tissue spindle cell sarcoma of the extremities results in a low local recurrence rate.

Clinical Relevance: Low-grade spindle cell sarcomas located at or distal to the elbow and stifle joints can be excised without need for wide or radical surgery.

Citing Articles

Evaluation of a targeted anti-αβ integrin near-infrared fluorescent dye for fluorescence-guided resection of naturally occurring soft tissue sarcomas in dogs.

Beer P, Grest P, Krudewig C, Staudinger C, Ohlerth S, Rohrer Bley C Eur J Nucl Med Mol Imaging. 2024; 52(3):1137-1148.

PMID: 39436437 PMC: 11754361. DOI: 10.1007/s00259-024-06953-x.


Surgical management of urethral obstruction secondary to perineal liposarcoma in a dog: a case report.

Korytarova N, Bosch B, Klass L, Slunsky P BMC Vet Res. 2024; 20(1):115.

PMID: 38521902 PMC: 10960436. DOI: 10.1186/s12917-024-03956-6.


Review of local extravascular delivery systems for chemotherapeutic agents in small animals and horses.

Risselada M, Worth D Can Vet J. 2023; 64(10):957-967.

PMID: 37780479 PMC: 10506355.


Scar revision for incompletely or narrowly excised soft tissue sarcomas in dogs.

Grimes J, Rajeev M, Wallace M, Laver T, Milovancev M Can Vet J. 2023; 64(1):70-75.

PMID: 36593932 PMC: 9754140.


Intratumoral injection of holmium-166 microspheres as neoadjuvant therapy of soft tissue sarcomas in dogs.

Morsink N, Nijsen J, Grinwis G, Hesselink J, Kirpensteijn J, van Nimwegen S Front Vet Sci. 2022; 9:1015248.

PMID: 36387397 PMC: 9664058. DOI: 10.3389/fvets.2022.1015248.